Nifty Pharma Corporate Filings & Announcements

Latest corporate announcements and filings from Nifty Pharma on BSE

Search Inside the pdf :

Torrent Pharmaceuticals Ltd.

19 Mar 2025, 07:50PM

3191.30

1.77%

Company Update

Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Intimation of Credit Rating

pdf

Cipla Ltd.

19 Mar 2025, 07:22PM

1499.15

-0.63%

Company Update

Cipla Ltd - 500087 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby notify that the Operations and Administrative Committee of the Company on 19th March, 2025 has allotted 2,179 fully paid up equity shares of INR 2 each pursuant to exercise of employee stock options/stock appreciation rights under the Employee Stock Option Scheme 2013-A and Cipla Employee Stock Appreciation Rights Scheme 2021 of the Company.

pdf

Alkem Laboratories Ltd.

19 Mar 2025, 04:57PM

4851.80

0.86%

Investor Presentation

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Please find enclosed herewith the presentation with respect to the Investor / Analyst Meeting scheduled to be held at ''HSBC Global Investment Summit 2025'' on 24th March, 2025 and 25th March, 2025 at Hong Kong.

pdf

Aurobindo Pharma Ltd.

19 Mar 2025, 01:19PM

1163.80

2.36%

Company Update

Aurobindo Pharma Ltd - 524804 - Classification Of US FDA Inspection At Unit V Of Apitoria …

BSE India

Intimation of classification of US FDA inspection at Unit V of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company

pdf

Aurobindo Pharma Ltd.

19 Mar 2025, 11:37AM

1163.80

2.36%

AGM

Aurobindo Pharma Ltd - 524804 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

BSE India

Submission of Results of Postal Ballot and Scrutinizer Report

pdf

Zydus Lifesciences Ltd.

18 Mar 2025, 05:08PM

909.90

0.86%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives final approval from USFDA for Apalutamide Tablets, 60 mg.

pdf

Granules India Ltd.

18 Mar 2025, 04:24PM

496.25

0.15%

Company Update

Granules India Ltd-$ - 532482 - Update

BSE India

Update

pdf

Lupin Ltd.

18 Mar 2025, 04:14PM

2060.95

1.29%

Company Update

Lupin Ltd - 500257 - Incorporation Of A Wholly Owned Subsidiary.

BSE India

The Company has incorporated a wholly owned subsidiary in the name and style ''LUPINLIFE Consumer Healthcare Limited'' under Corporate Identification Number U21002MH2025PLC443065.

pdf